ZBIO
Zenas BioPharma, Inc.
Company overview
- Market capitalization
- $1.80B
- Employees
- 167
- Latest publication
- 2026-09-29
About Zenas BioPharma, Inc.
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,000,000USD | 10,000,000USD | — | 0USD | 0USD | 10,000,000USD | 5,000,000USD | 0USD |
| Research Development | 62,913,000USD | 60,439,000USD | 55,720,000USD | 34,402,000USD | 43,027,000USD | 34,915,000USD | 49,157,000USD | 33,530,000USD |
| Selling General Administrative | 15,746,000USD | — | — | 13,178,000USD | 12,136,000USD | 12,415,000USD | 11,466,000USD | 7,254,000USD |
| General And Administrative Expenses | 15,746,000USD | — | — | 13,178,000USD | 12,136,000USD | — | — | — |
| Total Operating Expenses | 108,659,000USD | 77,350,000USD | 237,984,000USD | 52,580,000USD | 55,163,000USD | 47,330,000USD | 60,623,000USD | 7,454,000USD |
| Operating Income | -107,659,000USD | — | — | -52,580,000USD | -55,163,000USD | -37,330,000USD | -55,623,000USD | -40,984,000USD |
| Total Other Income Expense Net | -3,683,000USD | — | — | 1,081,000USD | 2,960,000USD | 3,552,000USD | 3,448,000USD | 2,378,000USD |
| Interest Income | 6,603,000USD | — | — | — | — | 3,394,000USD | — | — |
| Interest Expense | 1,720,000USD | — | — | — | — | 0USD | — | — |
| Income Before Tax | -111,342,000USD | — | — | -51,499,000USD | -52,203,000USD | -33,778,000USD | -52,175,000USD | -38,606,000USD |
| Income Tax Expense | 114,000USD | 205,000USD | 106,000USD | 0USD | 20,000USD | -205,000USD | 429,000USD | — |
| Net Income | -111,456,000USD | -80,987,000USD | -240,442,000USD | -51,499,000USD | -52,223,000USD | -33,573,000USD | -52,604,000USD | -38,606,000USD |
| Cost Of Revenue | — | — | — | — | — | 23,000USD | 33,000USD | 33,530,000USD |
| Gross Profit | — | — | — | — | — | 10,000,000USD | 5,000,000USD | -33,530,000USD |
| Net Interest Income | — | — | — | — | — | 3,394,000USD | — | — |
| Tax Provision | — | — | — | — | — | -205,000USD | — | 0USD |
| Net Income From Continuing Ops | — | — | — | — | — | -33,573,000USD | -52,604,000USD | -38,606,000USD |
| Ebit | — | — | — | — | — | -33,778,000USD | -55,623,000USD | -40,984,000USD |
| Ebitda | — | — | — | — | — | -33,755,000USD | -55,590,000USD | -40,948,000USD |
| Depreciation And Amortization | — | — | — | — | — | 23,000USD | 33,000USD | 36,000USD |
| Reconciled Depreciation | — | — | — | — | — | 23,000USD | 33,000USD | 36,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | -33,330,000USD |
| Source | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 10,000,000USD | 5,000,000USD | 50,000,000USD | 0USD |
| Research Development | 168,063,000USD | 139,139,000USD | 60,033,000USD | 62,689,000USD |
| Selling General Administrative | 53,322,000USD | 28,849,000USD | 17,114,000USD | 12,810,000USD |
| General And Administrative Expenses | 53,322,000USD | — | — | — |
| Total Operating Expenses | 393,057,000USD | 29,749,000USD | 87,147,000USD | 14,510,000USD |
| Operating Income | -383,057,000USD | -163,888,000USD | -37,147,000USD | -76,199,000USD |
| Total Other Income Expense Net | 5,241,000USD | 7,329,000USD | 324,000USD | -43,083,000USD |
| Interest Income | 12,151,000USD | 7,973,000USD | — | — |
| Interest Expense | 7,327,000USD | 0USD | — | — |
| Income Before Tax | -377,816,000USD | -156,559,000USD | -36,823,000USD | -119,282,000USD |
| Income Tax Expense | -79,000USD | 429,000USD | 301,000USD | — |
| Net Income | -377,737,000USD | -156,988,000USD | -37,124,000USD | -119,282,000USD |
| Cost Of Revenue | — | 139,139,000USD | 113,000USD | 61,689,000USD |
| Gross Profit | — | -134,139,000USD | 50,000,000USD | -61,689,000USD |
| Unclassified Operating Expenses | — | -138,239,000USD | 10,000,000USD | -60,989,000USD |
| Net Interest Income | — | 7,973,000USD | — | — |
| Tax Provision | — | 429,000USD | 301,000USD | 0USD |
| Net Income From Continuing Ops | — | -156,988,000USD | -37,124,000USD | -119,282,000USD |
| Ebit | — | -163,888,000USD | -27,147,000USD | -75,199,000USD |
| Ebitda | — | -163,751,000USD | -27,034,000USD | -75,121,000USD |
| Depreciation And Amortization | — | 137,000USD | 113,000USD | 78,000USD |
| Reconciled Depreciation | — | 137,000USD | 113,000USD | 78,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 701,690,000USD | 747,682,000USD | 383,640,000USD | 322,018,000USD | 293,085,000USD | 333,766,000USD | 369,968,000USD | 403,432,000USD |
| Cash And Equivalents | 196,577,000USD | 500,224,000USD | 110,641,000USD | 115,565,000USD | 44,006,000USD | — | — | — |
| Cash And Short Term Investments | 643,126,000USD | 718,500,000USD | 360,500,000USD | 301,600,000USD | 274,900,000USD | 312,379,000USD | 350,766,000USD | 386,799,000USD |
| Short Term Investments | 446,549,000USD | 216,981,000USD | 232,551,000USD | 175,319,000USD | 229,273,000USD | 115,825,000USD | 31,024,000USD | 26,761,000USD |
| Long Term Investments | 30,763,000USD | 1,340,000USD | 17,272,000USD | 10,717,000USD | 1,614,000USD | 1,835,000USD | 0USD | — |
| Total Current Assets | 653,794,000USD | 730,164,000USD | 351,171,000USD | 296,642,000USD | 278,603,000USD | 317,807,000USD | 355,923,000USD | 393,778,000USD |
| Other Current Assets | 10,668,000USD | 12,959,000USD | 7,979,000USD | 5,758,000USD | 5,324,000USD | 5,428,000USD | 5,157,000USD | 6,979,000USD |
| Other Non Current Assets | 16,289,000USD | 15,060,000USD | 13,809,000USD | 13,802,000USD | 11,797,000USD | — | — | — |
| Total Liabilities | 454,593,000USD | 411,853,000USD | 141,496,000USD | 125,590,000USD | 53,459,000USD | — | — | — |
| Total Current Liabilities | 65,818,000USD | 61,161,000USD | 62,649,000USD | 52,421,000USD | 53,244,000USD | 49,132,000USD | 57,292,000USD | 43,997,000USD |
| Other Current Liabilities | 57,406,000USD | 51,180,000USD | 54,423,000USD | 45,359,000USD | 44,520,000USD | — | — | — |
| Total Stockholder Equity | 247,097,000USD | 335,829,000USD | 242,144,000USD | 196,428,000USD | 239,626,000USD | 284,317,000USD | 312,458,000USD | 359,435,000USD |
| Total Equity Including Noncontrolling Interest | 247,097,000USD | 335,829,000USD | 242,144,000USD | 196,428,000USD | 239,626,000USD | — | — | — |
| Property Plant Equipment Net | 844,000USD | 1,118,000USD | 1,388,000USD | 857,000USD | 1,071,000USD | 1,276,000USD | 1,189,000USD | 545,000USD |
| Accounts Payable | 7,589,000USD | 8,944,000USD | 7,111,000USD | 6,444,000USD | 7,931,000USD | 20,018,000USD | 17,136,000USD | 15,082,000USD |
| Short Term Debt | 823,000USD | 1,037,000USD | 1,115,000USD | 618,000USD | 793,000USD | 908,000USD | 785,000USD | 384,000USD |
| Common Stock | 6,000USD | 6,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -957,571,000USD | -846,115,000USD | -765,128,000USD | -524,686,000USD | -473,187,000USD | -420,964,000USD | -387,391,000USD | -334,786,000USD |
| Accumulated Other Comprehensive Income | -1,141,000USD | -377,000USD | -64,000USD | -69,000USD | -94,000USD | 141,000USD | 194,000USD | 54,000USD |
| Long Term Debt | — | — | 78,636,000USD | 72,989,000USD | — | — | — | — |
| Total Liab | — | — | — | — | — | 49,449,000USD | 57,510,000USD | 43,997,000USD |
| Other Current Liab | — | — | — | — | — | 28,201,000USD | 39,160,000USD | 28,531,000USD |
| Capital Stock | — | — | — | — | — | 4,000USD | 4,000USD | 4,000USD |
| Cash | — | — | — | — | — | 196,554,000USD | 319,742,000USD | 360,038,000USD |
| Net Debt | — | — | — | — | — | -195,329,000USD | -318,739,000USD | -359,654,000USD |
| Short Long Term Debt Total | — | — | — | — | — | 1,225,000USD | 1,003,000USD | 384,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 1,276,000USD | 1,189,000USD | 545,000USD |
| Common Stock Shares Outstanding | — | — | — | — | — | 41,800,802shares | 41,790,000shares | 41,780,938shares |
| Non Current Assets Total | — | — | — | — | — | 15,959,000USD | 14,045,000USD | 9,654,000USD |
| Non Current Liabilities Total | — | — | — | — | — | 317,000USD | 218,000USD | 0USD |
| Non Currrent Assets Other | — | — | — | — | — | 12,848,000USD | 12,856,000USD | 9,109,000USD |
| Net Working Capital | — | — | — | — | — | 268,675,000USD | 298,631,000USD | 349,781,000USD |
| Unclassified Equity | — | — | — | — | — | 705,132,000USD | 699,647,000USD | 694,159,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 383,640,000USD | 369,968,000USD | 68,180,000USD | 74,579,000USD |
| Cash And Equivalents | 110,641,000USD | — | — | — |
| Cash And Short Term Investments | 360,500,000USD | 350,766,000USD | 56,857,000USD | 67,209,000USD |
| Short Term Investments | 232,551,000USD | 31,024,000USD | 0USD | — |
| Long Term Investments | 17,272,000USD | 0USD | — | — |
| Total Current Assets | 351,171,000USD | 355,923,000USD | 59,804,000USD | 68,444,000USD |
| Other Current Assets | 7,979,000USD | 5,157,000USD | 2,947,000USD | 1,235,000USD |
| Other Non Current Assets | 13,809,000USD | — | — | — |
| Total Liabilities | 141,496,000USD | — | — | — |
| Total Current Liabilities | 62,649,000USD | 57,292,000USD | 23,258,000USD | 25,967,000USD |
| Other Current Liabilities | 54,423,000USD | — | — | — |
| Total Stockholder Equity | 242,144,000USD | 312,458,000USD | -225,721,000USD | -192,286,000USD |
| Total Equity Including Noncontrolling Interest | 242,144,000USD | — | — | — |
| Long Term Debt | 78,636,000USD | — | 20,300,000USD | — |
| Property Plant Equipment Net | 1,388,000USD | 1,189,000USD | 1,014,000USD | 1,801,000USD |
| Accounts Payable | 7,111,000USD | 17,136,000USD | 5,396,000USD | 5,815,000USD |
| Short Term Debt | 1,115,000USD | 785,000USD | 556,000USD | 715,000USD |
| Common Stock | 5,000USD | 4,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -765,128,000USD | -387,391,000USD | -230,403,000USD | -193,279,000USD |
| Accumulated Other Comprehensive Income | -64,000USD | 194,000USD | 37,000USD | -41,000USD |
| Total Liab | — | 57,510,000USD | 293,901,000USD | 266,865,000USD |
| Other Current Liab | — | 39,160,000USD | 17,005,000USD | 19,437,000USD |
| Capital Stock | — | 4,000USD | 0USD | 0USD |
| Cash | — | 319,742,000USD | 56,857,000USD | 67,209,000USD |
| Net Debt | — | -318,739,000USD | -35,744,000USD | -65,682,000USD |
| Short Long Term Debt Total | — | 1,003,000USD | 21,113,000USD | 1,527,000USD |
| Property Plant Equipment Gross | — | 1,189,000USD | 1,014,000USD | 1,801,000USD |
| Common Stock Shares Outstanding | — | 41,785,469shares | 38,317,087shares | 38,317,087shares |
| Non Current Assets Total | — | 14,045,000USD | 8,376,000USD | 6,135,000USD |
| Non Current Liabilities Total | — | 218,000USD | 270,643,000USD | 240,898,000USD |
| Non Currrent Assets Other | — | 12,856,000USD | 7,362,000USD | 4,334,000USD |
| Net Working Capital | — | 298,631,000USD | 36,546,000USD | 42,477,000USD |
| Unclassified Equity | — | 699,647,000USD | 4,644,000USD | — |
| Unclassified Non Current Liabilities | — | — | 250,343,000USD | 240,898,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD |
|---|---|---|---|
| Depreciation | 10,000USD | 46,000USD | 35,000USD |
| Stock Based Compensation | 17,814,000USD | 18,767,000USD | 11,431,000USD |
| Change To Liabilities | 3,436,000USD | -5,908,000USD | -4,056,000USD |
| Change In Working Capital | -4,912,000USD | -11,958,000USD | -8,403,000USD |
| Operating Cash Flow | -132,433,000USD | -119,919,000USD | -78,794,000USD |
| Capital Expenditures | -2,000USD | -18,000USD | -18,000USD |
| Net Investments | -226,091,000USD | -153,504,000USD | -198,547,000USD |
| Unclassified Investing Cash Flow | -30,000,000USD | -5,000,000USD | — |
| Investing Cash Flow | -256,093,000USD | -158,522,000USD | -198,565,000USD |
| Common Stock Issuance | 592,000USD | 276,000USD | — |
| Unclassified Financing Cash Flow | 474,944,000USD | -839,000USD | — |
| Financing Cash Flow | 475,536,000USD | 74,437,000USD | 1,821,000USD |
| Effect Of Forex Changes On Cash | -1,074,000USD | -263,000USD | -288,000USD |
| Change In Cash | 85,936,000USD | -204,267,000USD | -275,826,000USD |
| End Cash Flow | 196,577,000USD | 115,565,000USD | 44,006,000USD |
| Net Debt Issuance | — | 75,000,000USD | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 6,000USD | -29,000USD | 11,000USD | -923,000USD | 23,000USD | 33,000USD | 36,000USD | 35,000USD |
| Stock Based Compensation | 9,195,000USD | 7,580,000USD | 7,336,000USD | 6,045,000USD | 5,386,000USD | 5,495,000USD | 2,843,000USD | 1,536,000USD |
| Change To Liabilities | -3,168,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | -4,687,000USD | 8,314,999USD | -3,664,000USD | 5,158,000USD | -8,858,000USD | 8,866,000USD | 4,544,000USD | 5,156,000USD |
| Operating Cash Flow | -75,196,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -2,000USD | -30,000,000USD | -5,000,000USD | 0USD | -18,000USD | -74,000USD | 0USD | -35,000USD |
| Net Investments | 31,613,000USD | — | — | — | — | — | — | — |
| Investing Cash Flow | 31,611,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 592,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 432,887,000USD | 1,611,000USD | — | — | — | — | — | 178,505,000USD |
| Financing Cash Flow | 433,479,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | -311,000USD | — | — | — | — | — | — | — |
| Change In Cash | 389,583,000USD | -4,924,000USD | 71,559,000USD | -152,548,000USD | -123,278,000USD | -40,295,000USD | 176,109,000USD | 146,776,000USD |
| End Cash Flow | 500,224,000USD | — | — | — | — | — | — | — |
| Net Income | — | -240,442,000USD | -51,499,000USD | -52,223,000USD | -33,573,000USD | -52,604,000USD | -38,607,000USD | -37,977,000USD |
| Other Non Cash Items | — | 172,162,000USD | 6,691,000USD | 200,000USD | -29,000USD | -344,000USD | 125,000USD | 291,000USD |
| Total Cash From Operating Activities | — | -52,414,000USD | -41,125,000USD | -41,743,000USD | -37,051,000USD | -38,554,000USD | -31,059,000USD | -30,959,000USD |
| Free Cash Flow | — | -52,414,000USD | -41,125,000USD | -41,743,000USD | -37,069,000USD | -38,628,000USD | -31,059,000USD | -30,994,000USD |
| Investments | — | -63,364,000USD | 40,043,000USD | -112,291,000USD | -86,274,000USD | -3,735,000USD | -26,760,000USD | -35,000USD |
| Total Cashflows From Investing Activities | — | -93,364,000USD | 40,043,000USD | -112,291,000USD | -86,274,000USD | -3,735,000USD | -26,760,000USD | -35,000USD |
| Total Cash From Financing Activities | — | 140,843,000USD | 72,616,000USD | 1,722,000USD | 99,000USD | 1,853,000USD | 233,980,000USD | 177,739,000USD |
| Issuance Of Capital Stock | — | 148,573,000USD | 0USD | 0USD | 0USD | 6,249,000USD | 234,387,000USD | — |
| Begin Period Cash Flow | — | 115,565,000USD | 44,006,000USD | 196,554,000USD | 319,832,000USD | 360,127,000USD | 184,018,000USD | 37,154,000USD |
| End Period Cash Flow | — | 110,641,000USD | 115,565,000USD | 44,006,000USD | 196,554,000USD | 319,832,000USD | 360,127,000USD | 183,930,000USD |
| Other Cashflows From Investing Activities | — | -30,000,000USD | -5,000,000USD | — | — | 6,000,000USD | -26,760,000USD | — |
| Other Cashflows From Financing Activities | — | -9,341,000USD | 71,676,000USD | 1,722,000USD | 99,000USD | -4,396,000USD | -439,000USD | -766,000USD |
| Unclassified Investing Cash Flow | — | 30,000,000USD | 10,000,000USD | — | — | -5,926,000USD | 26,760,000USD | — |
| Sale Purchase Of Stock | — | — | 276,000USD | — | — | — | — | — |
| Net Borrowings | — | — | — | — | 0USD | 0USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Depreciation | 56,000USD | 137,000USD | 113,000USD | 78,000USD |
| Stock Based Compensation | 26,347,000USD | 10,821,000USD | 3,495,000USD | 737,000USD |
| Change To Liabilities | 5,009,000USD | — | — | — |
| Change In Working Capital | -13,199,000USD | 25,431,000USD | -8,039,000USD | 7,967,000USD |
| Operating Cash Flow | -172,333,000USD | — | — | — |
| Capital Expenditures | -18,000USD | -131,000USD | -17,000USD | -2,198,000USD |
| Net Investments | -216,868,000USD | — | — | — |
| Unclassified Investing Cash Flow | -35,000,000USD | — | — | 4,198,000USD |
| Investing Cash Flow | -251,886,000USD | — | — | — |
| Net Debt Issuance | 75,000,000USD | — | — | — |
| Common Stock Issuance | 276,000USD | — | — | — |
| Unclassified Financing Cash Flow | 140,004,000USD | -178,381,000USD | — | -59,391,000USD |
| Financing Cash Flow | 215,280,000USD | — | — | — |
| Effect Of Forex Changes On Cash | -252,000USD | — | — | — |
| Change In Cash | -209,191,000USD | 262,889,000USD | -10,352,000USD | -8,500,000USD |
| End Cash Flow | 110,641,000USD | — | — | — |
| Net Income | — | -156,988,000USD | -37,124,000USD | -119,282,000USD |
| Other Non Cash Items | — | 925,000USD | 11,026,000USD | 44,848,000USD |
| Total Cash From Operating Activities | — | -119,674,000USD | -30,529,000USD | -65,652,000USD |
| Free Cash Flow | — | -119,805,000USD | -30,546,000USD | -67,850,000USD |
| Investments | — | -30,552,000USD | -17,000USD | -2,198,000USD |
| Total Cashflows From Investing Activities | — | -30,552,000USD | -17,000USD | -2,198,000USD |
| Net Borrowings | — | 0USD | 20,000,000USD | 0USD |
| Total Cash From Financing Activities | — | 412,958,000USD | 20,116,000USD | 59,391,000USD |
| Issuance Of Capital Stock | — | 419,017,000USD | 0USD | 59,391,000USD |
| Begin Period Cash Flow | — | 56,943,000USD | 67,295,000USD | 75,795,000USD |
| End Period Cash Flow | — | 319,832,000USD | 56,943,000USD | 67,295,000USD |
| Other Cashflows From Financing Activities | — | 172,322,000USD | 116,000USD | 59,391,000USD |
| Other Cashflows From Investing Activities | — | — | — | -2,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.